Save the Date for Applied Pharmaceutical Analysis 2020!

October 12- 14, 2020 Main Conference

Short Courses - Sunday, October 11, 2020

Boston Park Plaza
50 Park Plaza at Arlington Street
Boston, MA 02116

 

APA 2020 Plenary Speakers

Richard Yost APA2020   

Professor Richard A. Yost, PhD, Colonel Allen R. and Margaret G. Crow Professor, Department of Chemistry, University of Florida

Title TBD

 
     
Mark Rose APA2020  

Mark Rose, PhD, Director of Drug Metabolism and Pharmacokinetics, CHDI Foundation

The Role of Non-Profits in Drug Discovery and Development

     
rigoberto hernandez  

Professor Rigoberto Hernandez, PhD, Gompf Family Professor of Chemistry, Department of Chemistry, Johns Hopkins University

Value of Diversity, Inclusion and Equity in the Sciences

APA 2020 Invited Speakers

Jim Gllick APA2020

Jim Glick, PhD, Section Head, Translational and Investigational Labs, PK Sciences, Novartis

Immunogenecity Data and the Regulatory Landscape: Bioanalytical Lessons Learned from a Recent Biological Licensing Application Approval

  Jaya Goyal APA2020

Jaya Goyal, PhD, Vice President, Bioanalytical, Pharmacology, and Biomarker Development, Wave Life Sciences

Title TBA

         
Sean Kim APA2020

Sean Kim, PhD, Head, DMPK and Clinical Pharmacology, Bluprint Medicines

Title TBA

   

Min Meng, Deputy CEO at Chongqing Denali Medpharma, Co. Ltd

Title TBA

         
Chandra Prakash APA

Chandra Prakash, PhD, Senior Research Fellow, Agios Pharmaceuticals

Title TBA

   Andrew Rowland APA2020

Andrew Rowland, PhD, Associate Professor, Flinders Univeristy and Beat Cancer Research Fellow, Cancer Counsil SA

Exosome Markers for Drug Metabolism Pathways

         
Jim Shen APA 2020

Jim Shen, PhD, Director, Bioanalytical Science, Technical Outsourcing Management Lead, Bristol-Myers Squibb

Title TBA

   

Sekhar Surapaneni, PhD, Vice President, Nonclinical Disposition Assessment, Bristol-Myers Squibb

Challenges with Ozanimod Approval

         
 

Theingi Thway, PhD, Principal Scientist, Amgen

Bioanalysis in Therapeutic Biologics Development: Through the Lens of Industry and US-FDA

  Tu Yian APA2020 

Yu Tian, PhD, Director, Drug Metabolism and Pharmacokinetics, AbbVie

Microbiome Mediated Pro-Drug Metabolism and Application in Gut- Restricted Drug Design

         
Dr. Tee Zhang cropped

Tianyi Zhang, PhD, Executive Vice President of Frontage Laboratories Inc., and General Manager of Frontage China

Title TBA

   

 

         


Sessions for APA 2020 Workshops 

Regulated Bioanalysis

Regulatory Bioanalysis

When Bioanalytical Data were Critical to a Drug Product Submission or Approval

Regulatory/Immunogenicity Risk Assessments and Integrated Summary of Immunogenicity

Cell and Gene Therapy Bioanalysis in Regulated Environment

Chinese Bioanalytical Space/Regulatory Environment

Discovery Bioanalysis and New Technologies

New Technology and Platforms for Discovery Bioanalysis

Microbiome/Microbiota

Gene and Cell Therapy

HRMS/HRMS Quan

Mechanistic ADME

Drug-Drug Interactions

Unusual Approaches to ADME Studies

Metabolism and Toxicology - Predictive Approaches

ADME Challenges in Drug Approval - Case Studies

Combined Workshop

New Analytical Techniques - Biomarkers, Liquid Biopsy, Imaging

Exosomes (EV) and Biomarkers

 

 

Click to Download 2019 APA Program Guide

 Join our Linkedin Group:

Workshops

Regulated Bioanalysis

Discovery

Mechanistic ADME

Registration

Click here to register for the APA 2020 conference online.

APA 2020 will take place October 11-14th, 2020 at:

Boston Park Plaza Hotel

Boston, MA

 

The Boston Society

The Boston Society (R) is an internationally-recognized NON-PROFIT organization dedicated to bringing the best scientific ideas to industrial practice through focused, timely workshops and conferences. 501(c)3

Updates

Sign Up Today!

Privacy Policy